Sanofi Healthcare India Expands Global Capability Centre in Hyderabad with Rs 3600 Crore Investment
Written by Sirish Dixit
Sanofi Healthcare India announces Rs 3600 crore investment to expand its Global Capability Centre in Hyderabad by 2030, enhancing innovation and workforce.
Sanofi Healthcare India has announced a significant expansion of its Global Capability Centre (GCC) in Hyderabad, with a planned investment of Rs 3600 crore by 2030. This move is expected to bolster innovation, research, and development in the healthcare sector while substantially increasing its workforce.
The announcement was made during the inauguration of the facility at Hitec City, attended by Telangana Minister for Industries D Sridhar Babu, Secretary of the Department of Pharmaceuticals Arunish Chawla, and Special Chief Secretary for IT Jayesh Ranjan.
Sanofi's expansion in Hyderabad aligns with the Telangana government's vision to establish the state as a leading hub for healthcare innovation. The investment will enhance the GCC's capabilities, making it the largest of Sanofi's four global hubs within two years, with the workforce growing from 1,000 to 2,600 employees.
Emmanuel Frenehard, Sanofi’s Executive Vice President and Chief Digital Officer, emphasised the company's commitment to leveraging Artificial Intelligence (AI) across its value chain, from drug discovery to market deployment. He highlighted Sanofi's goal to become the first biopharma company powered by AI, ensuring ethical and safe AI use to accelerate drug development and improve productivity.
Madeliene Roach, Executive Vice President of Business Operations at Sanofi, stated that the investments would focus on acquiring talent and building new capabilities to support the large-scale operation, in addition to developing state-of-the-art facilities in Hyderabad.